- Report
- October 2025
- 120 Pages
Global
From €5136EUR$5,950USD£4,450GBP
- Report
- September 2025
- 120 Pages
Global
From €5136EUR$5,950USD£4,450GBP
- Report
- September 2025
- 180 Pages
Global
From €5136EUR$5,950USD£4,450GBP
- Report
- August 2025
- 145 Pages
Global
From €5136EUR$5,950USD£4,450GBP
- Report
- February 2025
- 100 Pages
Global
From €5136EUR$5,950USD£4,450GBP
- Report
- January 2026
- 184 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 185 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 180 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 199 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 182 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 191 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 187 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 186 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 193 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 194 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 190 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- January 2026
- 184 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- August 2025
- 185 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- August 2025
- 196 Pages
Global
From €3400EUR$3,939USD£2,946GBP
- Report
- August 2025
- 192 Pages
Global
From €3400EUR$3,939USD£2,946GBP

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more